Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 161

Results For "report"

1824 News Found

Venus Remedies H1 net profit rises 315%
News | November 03, 2021

Venus Remedies H1 net profit rises 315%

Venus Remedies has reported consolidated financial results for the period ended September 30, 2021


SOPHiA Genetics launches SOPHiA DDM to assist Agilent customers
Digitisation | November 02, 2021

SOPHiA Genetics launches SOPHiA DDM to assist Agilent customers

New bioinformatic workflow advances analysis capabilities for whole-exome assessment and interpretation


Lyka Labs  Q2FY22 consolidated PAT at Rs. 28.43Cr
News | November 01, 2021

Lyka Labs Q2FY22 consolidated PAT at Rs. 28.43Cr

Lyka Labs has reported consolidated financial results for the period ended September 30, 2021


GlaxoSmithKline posts Q2FY22 consolidated PAT at  Rs. 204.24 Cr
News | November 01, 2021

GlaxoSmithKline posts Q2FY22 consolidated PAT at Rs. 204.24 Cr

GlaxoSmithKline Pharmaceuticals Limited has reported consolidated financial results for the period ended September 30, 2021


Dr Reddys Laboratories  posts Q2FY22 PAT at Rs 992 Cr
News | November 01, 2021

Dr Reddys Laboratories posts Q2FY22 PAT at Rs 992 Cr

Dr. Reddy's Laboratories has reported consolidated financial results for the period ended September 30, 2021


Augnito launches first-ever Saas Fest in India
Digitisation | November 01, 2021

Augnito launches first-ever Saas Fest in India

The company is a medical dictation solution used by medical practitioners


Sun Pharma's Winlevi available in the US
Drug Approval | November 01, 2021

Sun Pharma's Winlevi available in the US

It is the first U.S. FDA approved novel topical mechanism for acne in nearly 40 years


Laurus Labs PAT at Rs 201.90 cr. in Q2FY21
News | October 29, 2021

Laurus Labs PAT at Rs 201.90 cr. in Q2FY21

Laurus Labs Limited has reported consolidated financial results for the period ended September 30, 2021


Zydus Wellness PAT at Rs. 21.47 cr. in Q2FY22
News | October 29, 2021

Zydus Wellness PAT at Rs. 21.47 cr. in Q2FY22

Zydus Wellness Limited has reported consolidated financial results for the period ended September 30, 2021


Transforming Healthcare Through AI
Opinion | October 29, 2021

Transforming Healthcare Through AI